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Abstract
Chitosan is a biocompatible polymer that has been widely studied for tissue engineering purposes.
The aim of this research was to assess bone regenerative properties of an injectable chitosan and
calcium phosphate-based composite and identify optimal degree of deacetylation (%DDA) of the
chitosan polymer. Drill holes were generated on the left side of a mandible in Sprague-Dawley rats,
and the hole was either left empty or filled with the implant. The animals were sacrificed at several
time points after surgery (7–22days) and bone was investigated using micro-CT and histology. No
significant new bone formation was observed in the implants themselves at any time points.
However, substantial new bone formation was observed in the rat mandible further away from the
drill hole. Morphological changes indicating bone formation were found in specimens explanted
on Day 7 in animals that received implant. Similar bone formation pattern was seen in control ani-
mals with an empty drill hole at later time points but not to the same extent. A second experiment
was performed to examine if the %DDA of the chitosan polymer influenced the bone remodeling
response. The results suggest that chitosan polymers with %DDA between 50 and 70% enhance
the natural bone remodeling mechanism.
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Introduction
Successful healing of bone tissue defects depends on several factors.
In clinical situations, where spontaneous healing is not achieved by
internal factors alone, external factors must be applied to stimulate
the healing process [1]. Healing in such cases is stimulated by
implants (IPs) providing osteogenic, osteoconductive and/or osteoin-
ductive properties, where bone grafts such as autografts, allografts
or synthetic graft substitutes are commonly used [2]. Autografts are
currently regarded as the golden standard in orthopedic surgery.
However, donor site morbidity is a serious drawback of the proce-
dure [3]. Synthetic grafts containing recombinant growth factors
such as bone morphogenic protein have been shown to be effective
in many applications [4]. However, because of safety concerns they
are only approved for a limited number of indications [5]. Hence, an
intensive search for replacement therapies is ongoing, involving de-
velopment of various types of innovative graft substitutes acting as
scaffolds that guide and promote new bone growth [6].
Chitosan is a natural, biodegradable and biocompatible polymer
that has a potential to act as a scaffold that promotes bone healing [7].
Chitosan is a linear polysaccharide comprising randomly distributed
b-(1 ! 4)-linked D-glucosamine and N-acetyl-D-glucosamine units.
Chitosan is produced by deacetylating chitin, an insoluble linear
b-(1 ! 4)-linked N-acetyl-D-glucosamine polysaccharide that serves
as a structural material in the exoskeleton of arthropods and cell walls
of fungi. The deacetylation process exposes positively charged amine
groups of the glucosamine units which increases solubility of the
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polymer [8]. In vitro studies suggest that chitosan has osteogenic prop-
erties as it promotes differentiation of stem cells into bone-forming
osteoblasts and promotes growth of bone colonies [9]. In vivo studies
suggest that chitosan alone is sufficient to stimulate osteogenesis
[10, 11]. In some previous studies, other materials with osteogenic,
osteoinductive and/or osteoconductive properties were added
to chitosan-based composites to further stimulate the bone healing
process [12, 13]. The IPs used in the present study were a combina-
tion of a chitosan polymer and a blend of tetracalcium phosphate
(Ca4(PO4)2O) and a-tricalcium phosphate (a-Ca3(PO4)2). Calcium
phosphate-based bone cement was chosen as a base for the IPs
because of its widespread clinical use and because it has been shown
to be biocompatible as well as osteoconductive [14].
The aim of the study was to assess the osteogenic properties of
chitosan and calcium phosphate-based IPs in a model of critical
bone lesion in the rat mandible. In a first set of experiments, osteo-
genic properties were assessed as a function of time using a single
type of chitosan polymer. In a second set of experiments, the opti-
mal degree of acetylation of the chitosan polymer was determined.
Materials and methods
Implants
Kits of the IP formulation were produced at the laboratories of
Genis hf., Iceland, consisting of 3.0% w/v of chitosan polymers with
different degree of deacetylation (96% DDA, 70% DDA and 50%
DDA) (Genis hf., Iceland), 30.9% w/v tetracalcium phosphate/a-tri-
calcium phosphate (Himed, USA), 4.2% w/v sodium glycerophos-
phate (Merck, Germany), 1.9% w/v calcium hydroxide
(Sigma-Aldrich, USA), 7.7% w/v phosphoric acid (Merck) and
water. The kits were sterilized by 20 kGray c-irradiation at
Radiation Center, Oregon State University, Corvallis, OR, USA.
Directly after mixing solid and liquid components, the IP material is
soft and injectable, but sets into a non-loadbearing solid within
24 h, with increasing hydroxyapatite content in the further course of
the setting reaction.
Animals and experimental design
First, time-dependent series: twenty-eight healthy Sprague-Dawley
rats (Tactonic, Denmark) were assigned to one of the following two
treatment groups: sham control (n¼12/group) and 70% DDA chi-
tosan composite IP (n¼16/group). These groups were then divided
into four subgroups of three animals for sham control subgroups
and four animals for chitosan composite IP subgroups with different
durations of life phase: 7, 10, 14 and 22 days. One animal from the
22 day group died in surgery and was used as an example for Day 0.
Second series testing the effect of %DDA of the chitosan poly-
mer in the IP: 36 healthy Sprague-Dawley rats (Tactonic, Denmark)
were assigned to one of the following four treatment groups: sham
control (n¼10/group); 50% DDA chitosan composite IP (n¼12/
group); 70% DDA chitosan composite IP (n¼6/group) and 96%
DDA chitosan composite IP (n¼8/group). All animals were sacri-
ficed 7 days post-operatively. The observation time of 7 days was
chosen as the results from the time-dependent study had indicated
highly dynamic growth at this time point and thus a high sensitivity
of the model toward %DDA was expected.
Animal feed was obtained from Special Diet Services, Essex,
England.
All experiments were designed and conducted according to the
FELASA guidelines and approved by the Icelandic Veterinarian
Scientific Ethical Authorities.
Surgical procedure
The animals were anesthetized with Hypnorm/Dormicum and re-
ceived prophylactic antibiotic treatment with trimethoprim 80 mg/ml,
sulphadiazine 400mg/ml, 0.0005ml/g rat subcutaneous (s.c.) prior to
surgery and 1 day post-operatively. To compensate for blood and fluid
loss 5 ml of Ringers Acetate were injected subcutaneously. Skin of the
jaw was disinfected with alcoholic iodine prior to surgery. The skin
was incised longitudinally along the posterior edge of the mandible.
The masseteric muscle was released subperiosteally from the edge of
the bone and masseteric fossa exposed. A hole was drilled into the cen-
tral part of the masseteric fossa with a 4-mm dental drill (Fig. 1A).
Thereafter, bone debris was thoroughly rinsed from the drilled area by
flushing with 5 ml sterile saline water. In the first experiment, the void
was filled with 40ml of the IP formulation using a syringe without an
attached needle (Fig. 1B and C) or left untreated (control). In the sec-
ond experiment the IP volume was decreased to 25ml because 40ml
proved to be excessive as IP material tended to smear out around the
drillhole. The surgical wound was closed with 4–0 polyglactin running
s.c. suture and the skin with 4–0 polyamide nonabsorbable running
suture. Blood loss was estimated by weighing the dental rolls used for
soaking up blood during surgery. For post-operative analgesia, either
Butorphanol 2 mg/kg or Buprenorphine 0.05mg/kg, was given no later
than 4 h after induction of anesthesia, or as soon as the animal started
moving post-operatively. The time span for analgesic treatment was
estimated on basis of behavior suggesting freedom from pain and dis-
tress. During surgery and until ambulatory, animals were kept on a
heat mat under continuous observation, monitored for body
Figure 1. Overview of surgery in a rat receiving implant. (A) Dental drill was used to drill the hole. (B) Implant injected into the hole. (C) Appearance of tissue after
implantation showing how implant fills the hole
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temperature, consciousness, respiratory frequency as well as signs of
pain and distress. Animals still showing distress symptoms after 48 h
post-operatively, received further analgesic treatment as needed.
Surgery was well tolerated by all except one animal from the
22 days group, which died of excessive bleeding due to a rupture of
the sublingual artery. One rat from the control group had a swollen
neck for 3 days post-operation but body temperature was stable and
within normal limits. All rats lost some weight during the first days
after surgery but had reached their pre-operative body weight
1 week post-operatively. No other complications were recorded.
All animals were sacrificed by injection of an overdose of
Hypnorm/Dormicum intraperitoneally. To secure death before dis-
section the aorta was cut off the heart. Left masseteric muscle was
released from the mandible bone and inspected macroscopically for
infection or necrosis. Thereafter the jaw bone was explanted and
cleaned from soft tissue and the mandible placed in a fixation media
containing 3.7% formaldehyde in a sodium phosphate buffer at pH
7. The most common macroscopic finding during autopsy was a
pale discoloration of the inner surface of the masseteric muscle, in
the area just above the drill hole in the mandibular bone, most prob-
ably caused by the dissection from the bone during the surgical
procedure.
X-ray micro-CT analysis
Scanning was performed in an x-ray micro computed tomography
(CT)-scanner (Nanotom, General Electric Inspection Technologies).
Samples were fixed in a closed plastic cylinder filled with 3.7% buff-
ered formaldehyde solution and mounted on the rotational table in
the CT-scanner. Scans were performed with an aluminum phantom
and a plastic phantom (PET) as reference points for gray value com-
parison. Magnification was 4, voxel size 12.50mm/voxel edge, num-
ber of images collected 1080 (step size 0.33), with exposure time of
2000 ms, frame averaging of 3, and 1 frame skipped. X-ray settings
were 100 kV, 80–85 and 125mA, using tube mode 0 and no filter.
Volume reconstruction was performed using the Datos-x software
accompanying the CT-scanner. Data analysis was performed using
Volume Graphics Studio Max 2.0 from Volume Graphics.
New bone appears darker on the grayscale than old bone since it
has a lower mineral content. Old bone could be segregated from
new bone by grayscale separation but since the IP composite exhib-
ited similar grayscale values as new bone, the IP volume had to be
subtracted to get a measure of new bone formation. A large cylinder
(LC) of 9 mm radius and 14 mm length was defined which com-
prised the entire bone extending back from the hindmost molar, in-
cluding the head of mandible, angle of mandible, coronoid process
and the hole with or without an IP (Fig. 2). In all cases, a smaller cyl-
inder (SC) was defined around the hole, perpendicular to the mandi-
ble. This cylinder was used to isolate the IP as well as the remaining
bone splinters left in the hole. By defining a grayscale value interval,
the combined volume of old bone, new bone and IP material within
LC and SC was determined manually. Total bone volume (TBV)
expressed in cubic millimeters was established as the sum of voxel
volume defined by the specified grayscale value interval within LC,
subtracted by the voxel volume measured in SC. In this way, an esti-
mate of the TBV (new and old bone) of all jaws was obtained and
comparison between treatment groups made possible.
Histology
Histological evaluation was used to confirm the characterization of
bone structures seen in the CT images, as old versus new bone.
Specimens from mandibles were decalcified in hydrochloric Decalc
solution (Histolab product AB, Sweden), for 30 min to 1 h. Then tis-
sue specimens were put into cassettes and tissue rinsed in running
tap water for 30 min. Next step was the conventional method of tis-
sue processing overnight in an automatic tissue processor (Tissue
Tek VIP, Sakura) ending with paraffin embedding where the tissue
is embedded in paraffin wax at 63C. Paraffin blocks were then
moved over to a cooling plate for hardening and after that to a mi-
crotome for sectioning (Leica RM2255, Fully Automated Rotary
Microtome). Disposable blades were used (Accu-Edge Disposable
Blades, Sakura) for cutting sections at 3mm thickness. Sections were
mounted on coated microscope slides (Star Frost 7626 mm,
Knittel Glas GmbH, Germany), dried in a 60C oven for 60 min.
Ten sections were taken from each paraffin block at 12 mm intervals
each and mounted on 10 Star Frost slides marked with specimen
number and Roman numerals from I to X. After drying, H&E stain-
ing was performed using Shandon instant Hematoxylin and Eosin
solution (Sigma-Aldrich).
Statistical analysis
For statistical analysis SigmaPlot 13 (Systat Software, Inc.) was
used. ANOVA and Student’s t-test (two tailed) were used for com-
parison of groups. The level of significance was accepted at
P<0.05.
Results
Observation of bone remodeling in response to IP
Histological analysis showed polymorphonuclear (PMN) cells in-
vading the outer edges of the IP which was surrounded by a vascular
Figure 2. Standardization of a partial mandibular volume from micro-CT data according to anatomical landmarks in order to enable comparison of total bone vol-
ume. Orientation of the larger cylinder (LC) embracing the entire posterior part of the mandible. One end of the cylinder was positioned so as to sit on the inner-
most molar and the orientation of the cylinder was adjusted so as to be perpendicular to an imagined plane sitting on HM and the end of the angular process.
The smaller cylinder (SC) also indicated covered the drillhole encompassing all remaining bone splinter as well as the implant
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fibrous tissue (VFT). Outside the VFT, new bone tissue was ob-
served, derived from bone remodeling of the old bone tissue (OB).
Histological analysis of samples from all time points of the time-
dependent experimental series revealed similar results; an example
of how an IP looks 14 days after surgery is shown (Fig. 3A). By
selecting micro-CT sections in the same plane as histological sections
it was tested whether micro-CT analysis correlated with histological
analysis. Using this approach it could be shown that these methods
correlate well as both can distinguish between new and old bone
(Fig. 3B). The appearance of the IP was similar throughout the time
course examined and no significant new bone formation was ob-
served in the IP at any of the time points (Fig. 4). Control animals
with empty drill holes showed similar VFT formation surrounding
the drill hole (histological data not shown), proximal bone remodel-
ing and little new bone formation in the drill hole (Fig. 4C).
Since no new bone formation was observed at the site of the IP
we extended our search and looked at the whole left side of the man-
dible using micro-CT. Comparative micro-CT analysis of this por-
tion of the mandible suggested that new bone was forming along the
mandibular angle (MA) and around the drill hole. Figure 5 shows
transverse micro-CT sections of the mandible at several different
time points and shows that new tissue has formed as early as 7 days
after surgery. For clarity, the sample in Fig. 5B showing IP from Day
0 came from an animal that had only had the IP for a few hours, the
IP had not settled and was therefore not fully preserved with the
sample. For the other time points, the IP itself was proportionally
large compared with the thickness of the bone and did not seem to
undergo any degradation during the experimental period. On Day 7,
partially mineralized new bone tissue was found in areas surround-
ing the hole and along the MA. On Days 10–22, volume of new
bone had visibly increased around the hole, both on the interior and
exterior sides of the mandible. Figure 6 shows a control sample and
a sample with an IP 14 days after surgery. In response to the injury
mineralized tissue is forming in areas surrounding the hole in control
samples, especially on the exterior side. In the IP sample a consider-
ably larger volume of new mineralized tissue has formed in the same
areas, as well as on the interior side. Figure 6 also shows for compar-
ison a sample from an animal that died in surgery (Day 0).
Quantification of bone formation and remodeling by
micro-CT
Since new bone was forming in the vicinity of the IP but not in the
IP itself a different approach than originally planned was taken to
Figure 3. (A) Drilled hole with 14days old implant (IP) containing PMN leukocytes (PMN) stained blue in the outer rim of the implant, then vascular fibrous tissue
(FT), then new trabecular bone (NB). Original bone is on the left (OB) and the edge between old and new bone is indicated (arrow). Undissolved chitosan can be
seen in the implant (C). (B) Virtual sectioning through a micro-CT image of the same sample. Drilled hole with implant (IP) then vascularized fibrous tissue (VFT,
dark layer), then new trabecular bone (NB). Original bone (OB) is on the left
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analyze the samples, looking at a larger volume around the IP rather
than the IP itself. New bone appears darker than old bone on micro-
CT images, therefore, these can be separated using a defined gray-
scale value. However, for our study the IP had similar grayscale
value distribution as new bone. Therefore, the IP volume was sub-
tracted and TBV outside of the IP was calculated (see Fig. 2 and
Materials and methods). Changes in TBV were rapid during the first
10 days in all rats but after that, a plateau was reached in both
groups (Fig. 7). From Days 7 to 10 the control group showed a 15%
increase in TBV and the experimental group showed a 24% in-
crease. According to a two-tailed t-test, statistically significant in-
crease in TBV between control and IP was observed at all time
points, with P<0.01 for 7, 10 and 14 days and P<0.05 for
22 days.
Degree of acetylation affects bone remodeling
To extend these findings, verify the model and examine how acetyla-
tion of the chitosan polymer affected the results, another experiment
was performed. Experimental procedure was identical except here a
single time point of 7 days was used and the IP volume was de-
creased from 40 to 25ml. The test groups included a control group
with an empty drill hole and three IP groups with a chitosan poly-
mer of various degree of deacetylation, 96% DDA, 70% DDA and
50% DDA. TBV was calculated for each group (Fig. 8). The largest
volume increase relative to control was in the 70% DDA group. The
TBV was 16% higher than in the control group. The difference
between the 50% DDA group and control was 12% but the 96%
DDA group did not show a significant increase in the TBV in 7 days
relative to control. According to a one-way analysis of variance
(ANOVA), a significant difference in TBV was observed between
control and IP with 50% DDA as well as between control and IP
with 70% DDA, with P<0.01. The difference in TBV between IPs
with 50% DDA and 70% DDA was not statistically significant as
judged by a t-test.
Discussion
The findings of the present study are that a calcium phosphate-based
IP containing 50–70% DDA chitosan polymer may stimulate new
bone growth. However, new bone growth was not observed in the
IP itself but rather in surrounding bone tissue. Three-dimensional
representations produced from the X-ray micro-CT data showed
new bone growth formed as an outgrowth from the periosteum, cov-
ering the surface of the bone, located along particular areas of the
mandible. This finding suggests that it is the biomechanical weaken-
ing in the structure of the mandible that stimulates the osteogenesis
observed in the present material. The rats cannot shield the mandi-
ble as they need to feed, therefore, there is a greater need to compen-
sate for loss of mechanical strength or stability produced by the drill
hole. In the time course experiment this compensation was observed
in both empty drill hole controls and animals which received the
70% DDA chitosan and calcium phosphate IP. The important
Figure 4. Micro-CT image sectioning of implant comparing Day 7 (A) and Day 22 (B). (C) Control sample at Day 22. No significant bone formation was observed in
the implants. In the control sample, little new bone (*) formation was observed
Figure 5. The effect of implant on mineralized tissue formation as a function of time in the rat mandible. (A, left): Overview of the interior side of the mandible indi-
cating the drilled hole. Yellow line shows the location of the transverse section. (B, right): Four transverse sections of 0, 7, 10 and 14days post operation showing
the implant (p) and the formation of new mineralized tissue (*). i, interior side; MA, mandibular angle; CP, condylar process; MH, head of mandible. For the 0days
time point, rats were sacrificed at the same day as the operation
Bone remodeling effect of a chitosan and calcium phosphate-based composite 245
D
ow
nloaded from
 https://academ
ic.oup.com
/rb/article-abstract/6/4/241/5384505 by Landspitali U
niversity H
ospitals user on 26 Septem
ber 2019
finding here is that this response was stronger and faster in the IP
group. We further show that an IP with a 50% DDA chitosan poly-
mer showed similar results as an IP containing 70% DDA chitosan
polymer but an IP comprising 96% DDA chitosan polymer was not
as effective. It can be speculated that the chitosan is increasing or
stimulating a natural response to the structural weakening of the man-
dible and that the acetyl groups in the chitosan polymer play a role.
Chitinases cleave chitin and partly deacetylated chitin, but not
fully deacetylated chitosan. Chitinases, including human chitinases
(Chitotriosidase) need at least two consecutive acetylated glucos-
amine units (AA) on the partly deacetylated chitin polymer in order
to cleave it into oligomers, resulting in AA at the reducing end of
each oligomer product [15–17]. Chitinases and chitinase like pro-
teins are highly expressed during inflammation [18], e.g. by immune
cells such as PMN leukocytes. Therefore it is likely that the exposed,
partly deacetylated chitosan polymer (50 and 70% DDA) is cleaved,
forming oligomers locally during the inflammation phase in the drill-
hole wound, as the IP is slowly disintegrated. The highly deacetylated
chitosan (96% DDA) is likely to be sparsely cleaved. The degree of
deacetylation of chitooligosaccharides controls the binding affinity
to the chitinase like protein YKL-40 and the effect on human chon-
drocyte proliferation [19]. Fully deacetylated hexamer binds very
poorly to YKL-40 [19]. Chitosan having different degree of deacetyla-
tion has been shown to have different biological activity, where lower
Figure 6. Three-dimensional reconstruction from micro-CT data comparing a control sample and a sample with implanted composite with 70% DDA chitosan af-
ter 14 days of incubation. The control sample (center) shows some thickening of the bone around the hole as a natural response to the injury. The sample with im-
plant (right) shows a much more distinct thickening of the bone in the same areas around the hole. As a reference, a sample from an animal that died in surgery
is shown (left). As the implant material did not have time to set, most of it was washed away, leaving some remnants around the hole
Figure 7. Change in total bone volume in a defined part of rat mandible as
a function of time. Results from two-tailed t-test, statistical significance be-
tween control and implant groups for each time is indicated (*P< 0.05,
**P< 0.01). Graphs represent mean6SEM
Figure 8. Change in total bone volume in a defined part of rat mandible
as a function of implant type (%DDA). Results from one-way ANOVA compar-
ing all treatment groups to the control (**P<0.01). Graphs represent
mean6SEM
246 Kjalarsdo´ttir et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/rb/article-abstract/6/4/241/5384505 by Landspitali U
niversity H
ospitals user on 26 Septem
ber 2019
degree of deacetylation (higher acetylation; more chitin like) has the
tendency to have stronger bioactivity. When comparing the effect of
fully acetylated and deacetylated chitooligosaccharides (Hexamers)
on osteogenic differentiation of bone-marrow derived human mesen-
chymal stem cells, the effect of chitooligosaccharides was dependent
on the acetylation degree, with significantly stronger effects with
chitin-derived hexamers (N-acetyl chitohexaose; fully acetylated) than
with chitosan hexamers (chitohexaose; fully deacetylated) [20].
Our histological analysis shows that the 70% DDA chitosan IP
attracts PMN leukocytes and we know that a 70% DDA chitosan
polymer is a good chitinase substrate and will produce chitooligo-
saccharides of various sizes [21]. Therefore, it is possible that the IP
is acting as a reservoir, allowing slow release of chitooligosacchar-
ides which can diffuse from the IP and stimulate new bone growth
in the periphery of the IP [21]. The reason the 96% DDA chitosan is
not as effective might be because it is not a good substrate for chiti-
nases, with only 4% of the units being N-acetyl-glucosamine.
When we compare our results to the literature it is surprising
that we do not see any activity in the IP itself. However, the duration
of this study might not be long enough to see osteogenesis in the IP.
Furthermore, the IP is non-load bearing, and so does not impart the
mechanical signal needed for active bone formation and remodeling.
Other published studies generally allow more time to pass before
checking for bone growth [12]. The peripheral bone growth has not
been reported by other groups researching bone regenerative effects
of chitosan IPs/scaffolds. One reason might be that this would gener-
ally get overlooked by researchers that are focusing on the IP itself.
Another reason might be that the rat mandible model is especially
sensitive to mechanical stress induced bone remodeling since the
mandible cannot be shielded, even after an injury, because the ani-
mals need to feed. On the other hand, it might also be because at
later time points this bone has been reabsorbed. At the time points
that we selected, not enough time has subsided for the IP to be
replaced by new bone, therefore, compensations need to be made in
other areas of the mandible. As time passes bone might replace the
IP and then the reinforcements around the bone defect might no lon-
ger be needed, perhaps causing resorption of the extra bone gener-
ated at earlier time points. The answer to these speculations can
only be acquired by additional studies.
For clinical use in bone defects, the results point to the option of
developing a chitosan containing scaffold or a composite IP that
takes up mechanical load within the defect, and facilitates cell in-
growth, in order to stimulate osteogenesis within the defect.
Conclusions
The results of the present study suggest that the bone regenerating
effect of mechanical stimulation of the bone tissue is increased by
chitosan or chitooligosaccharide containing IPs.
The effect on bone regeneration also depends on the degree of
deacetylation of the chitosan used.
Use of chitosan-calcium phosphate soft composites as bone void
fillers is not feasible for short-term stimulation of osteogenesis
within a void. For restoration of function, a soft composite may still
be feasible as a reservoir of chitosan, accelerating osteogenesis in the
vicinity of the IP site.
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